Ratings Aier Eye Hospital Group Co., Ltd.

Equities

300015

CNE100000GR6

End-of-day quote Shenzhen S.E. Other stock markets 13/09/2024			5-day change	1st Jan Change
9.330 ^CNY	-2.10%		+0.21%	-41.02%

26/08	Citi Downgrades Aier Eye Hospital Group to Sell From Neutral; Price Target is 7 Yuan	MT
26/08	Aier Eye Hospital Group H1 Profit Up 20%, Operating Income Rises 3%	MT

Summary: Aier Eye Hospital Group Co., Ltd.

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Highlights: Aier Eye Hospital Group Co., Ltd.

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The company returns high margins, thereby supporting business profitability.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses: Aier Eye Hospital Group Co., Ltd.

The company's enterprise value to sales, at 3.61 times its current sales, is high.
The company appears highly valued given the size of its balance sheet.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The company's earnings releases usually do not meet expectations.

Ratings Chart: Aier Eye Hospital Group Co., Ltd.

Source: Surperformance

ESG chart: Aier Eye Hospital Group Co., Ltd.

Source: Refinitiv

Sector Comparison:

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Capi. ($)
AIER EYE HOSPITAL GROUP CO., LTD.		12.23B
BANGKOK DUSIT MEDICAL SERVICES		13.99B
IHH HEALTHCARE		13.88B
APOLLO HOSPITALS ENTERPRISE LIMITED		12.03B
ENCOMPASS HEALTH CORPORATION		9.38B
THE ENSIGN GROUP, INC.	-	8.66B
RAMSAY HEALTH CARE LIMITED		6.27B
MOUWASAT MEDICAL SERVICES COMPANY		5.47B
FORTIS HEALTHCARE LIMITED		5.26B
DALLAH HEALTHCARE COMPANY		4.18B
Average		9.13B
Weighted average by Cap.

See all sector ratings

Investor Rating

Trading Rating

ESG Refinitiv

B+

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes